Evotec Wins € 7.5 Mill Grant for Development of First-in-class COVID-19 Therapeutic
Evotec, a publicly listed drug discovery and development company, has won a € 7.5 million grant for the development of
Read more
R&D
Life Science Unit of Merck KGaA Sees 30.7% Q3 EBITDA Growth
German multinational science and technology company Merck KGaA announced its Life Science unit, which supplies tools and materials for the
Read more
SCIEX and Evosep Collaborate to Enhance High-Throughput Proteomics
SCIEX and Evosep have established a collaboration to co-market solutions designed to enhance the stability of high-throughput proteomics systems for
Read more
First Evotec-BMS Academic BRIDGE Collaboration Projects to Focus on Oncology
The first two projects funded within the translational BRIDGE beLAB1407 collaboration will focus on new mechanisms to treat cancer, Evotec
Read more
EUCODIS‘ Scientists Help Pave the Way Towards Better Understanding of LPMOs
Scientists from EUCODIS Bioscience, a leading Austrian enzyme engineering and manufacturing company, have contributed to new findings on structural and
Read more
Rosalind Franklin Institute, Novel Biological Imaging Technologies, UK
The Rosalind Franklin Institute, a new research institute dedicated to developing novel technologies to tackle important health research challenges has
Read more
Boehringer Ingelheim and Twist Form Therapeutic Antibody Discovery Partnership
Boehringer Ingelheim and Twist Bioscience have entered into a research collaboration that covers multiple antibody research programs. Twist Bioscience Corporation,
Read more
COVID-19 antibodies enable tissue-based detection of viral infection
HistoSure’s novel monoclonal COVID-19 antibodies developed to enable tissue-based detection of viral infection in human clinical samples have shown excellent
Read more
Machine Learning Tissue Classifiers Power AI in Clinical Research
Machine learning tissue classifiers are one of the most powerful and promising AI-based clinical research solutions for all types of
Read more
Sanofi to Invest €400 Million Annually in First-ever mRNA Vaccine Center of Excellence
Pharma giant Sanofi will spend €400 million annually towards a vaccines mRNA Center of Excellence, which will be the first
Read more